Serum bilirubin is inversely correlated with diabetic retinopathy predicting progression of retinopathy over time.
Read More »Glucose Control and Microvascular Complications
Big changes to affect small vessels.
Read More »Children, Adolescents With Diabetes Might Be Missing Out on Retinopathy Screenings
Race, socioeconomic status thought reasons behind lack of adherence to the recommendations.
Read More »American Diabetes Association Updates on Diabetic Retinopathy
Improvements in assessment and treatment of diabetic retinopathy position statement
Read More »2017 ADA Position Statement on Diabetic Retinopathy
This represents the first such update by the American Diabetes Association since 2002, and is notable for inclusion of the latest evidence and recommendations with respect to appropriate eye examination intervals, referral criteria, prevention of incidence and progression of diabetic retinopathy (DR), and treatment strategies.
Read More »Fenofibrate Therapy in Diabetic Retinopathy
Studies suggest fenofibrate can prevent microvascular changes, decrease need for surgery.
Read More »Dr. A. Paul Chous Part 4, Diabetes Visual Function
In part 4 of this Exclusive Interview, Dr. Chous discusses his findings during a clinical trial of a multi-component supplement used to intervene in the development of diabetic retinopathy and improve visual function.
Read More »Expensive Drugs to Treat Diabetic Macular Edema Not Cost-Effective
The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than bevacizumab, are not cost-effective for treatment of DME compared to bevacizumab unless their prices decrease substantially, according to a study published online by JAMA Ophthalmology.
Read More »Dr. A. Paul Chous Part 3, What’s New in the Treatment of Diabetic Eye Disease
In part 3 of this Exclusive Interview, Dr. Chous gives a brief tour of what's on the horizon in treating diabetic eye disease.
Read More »Dr. A. Paul Chous Part 2, A1C Impact on Treatment of Vision Impairment
In part 2 of this Exclusive Interview, DIC Publisher Steve Freed asks about the success of anti-VEGF agents with lower A1Cs.
Read More »